5th Feb 2019 10:49
LONDON (Alliance News) - Clinigen Group PLC on Tuesday said it appointed Nick Keher as group chief financial officer with effect from March 19.
Keher replaces current CFO Martin Abell, who resigned from the company and will leave on March 31.
Keher joins the pharmaceutical company from Royal Bank of Canada where he was a managing director and head of its European Healthcare equity research team. He has covered the European healthcare space for over eight years at both RBC and Investec, the company explained.
Keher is also a qualified pharmacist after completing his degree from Aston University.
"Nick brings considerable pharmacy and pharmaceutical experience as well as financial expertise, both as an accountant and from working in the financial markets. He has a deep knowledge and insight of our business through his research and analysis of Clinigen since its initial public offering in 2012. He will be a key addition to the executive management team," Chief Executive Officer Shaun Chilton said.
Clinigen shares were trading down 2.4% at 791.50 pence each.
Related Shares:
CLIN.L